Clinical Trial Update: Lenalidomide and Recombinant Human Stem Cell Factor for Treatment of Myelodysplasia [EARLY_Phase 1]

View source ↗

Summary

This document describes an early-phase 1 clinical trial evaluating lenalidomide in combination with recombinant human stem cell factor for the treatment of myel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Drugs mentioned

• Lenalidomide (Revlimid) (lenalidomide)
• Recombinant human stem cell factor (recombinant human stem cell factor)

Snippet

Sponsor: Peter MacCallum Cancer Centre, Australia | Conditions: Myelodysplasia | EARLY_Phase 1 | Status: UNKNOWN